MBP metabolic pharmaceuticals limited

10.5 m capital raising, page-9

  1. 10,754 Posts.
    lightbulb Created with Sketch. 53
    I think they also stated that they will need to fast track once the results are out. Marketing (if they do this alone) is expensive. Doing deals costs heaps. Also, there are other exciting drugs (competition) that are coming out soon. They have to have the edge !
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.